Open Access. Powered by Scholars. Published by Universities.®
Articles 31 - 60 of 309
Full-Text Articles in Medicine and Health Sciences
Are We Failing To Stop Huntington’S Disease By Ignoring 'Natural' Remedies, Alternative Therapies, And Repurposed Drugs?, Kenneth P. Serbin
Are We Failing To Stop Huntington’S Disease By Ignoring 'Natural' Remedies, Alternative Therapies, And Repurposed Drugs?, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
As Range Of Possible Therapies Grows, Chdi Expands Efforts To Defeat Huntington's Disease, Kenneth P. Serbin
As Range Of Possible Therapies Grows, Chdi Expands Efforts To Defeat Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
What If We Could Turn Off The Cause Of Huntington’S Disease?, Kenneth P. Serbin
What If We Could Turn Off The Cause Of Huntington’S Disease?, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Factor-H Partners With Latin American Organizations To Aid Destitute Huntington's Disease Families, Seeks To Expand Support, Kenneth P. Serbin
Factor-H Partners With Latin American Organizations To Aid Destitute Huntington's Disease Families, Seeks To Expand Support, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘Dancing At The Vatican,’ About Huntington’S Families' Remarkable Papal Audience, Premieres July 27, Kenneth P. Serbin
‘Dancing At The Vatican,’ About Huntington’S Families' Remarkable Papal Audience, Premieres July 27, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Restarts Redesigned Phase 3 Huntington’S Disease Trial, Kenneth P. Serbin
Roche Restarts Redesigned Phase 3 Huntington’S Disease Trial, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Are Pre-Existing Conditions Returning, And Obamacare Ending?, Kenneth P. Serbin
Are Pre-Existing Conditions Returning, And Obamacare Ending?, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
My Huntington’S Disease Sister – And A Hero Who Strives For The Unthinkable, Kenneth P. Serbin
My Huntington’S Disease Sister – And A Hero Who Strives For The Unthinkable, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘Let’S Talk About Huntington’S Disease’: 2019 Hd Awareness Month Kicks Off, Kenneth P. Serbin
‘Let’S Talk About Huntington’S Disease’: 2019 Hd Awareness Month Kicks Off, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Comedian Rod Man’S Heartfelt Speech, Ramona Johnston's Death Remind Us Of Urgent Need To Cure Huntington's Disease, Kenneth P. Serbin
Comedian Rod Man’S Heartfelt Speech, Ramona Johnston's Death Remind Us Of Urgent Need To Cure Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche: Less Frequent Dosing For Phase 3 Huntington's Clinical Trial, Easing Burden On Patients, Kenneth P. Serbin
Roche: Less Frequent Dosing For Phase 3 Huntington's Clinical Trial, Easing Burden On Patients, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Ramps Up Huntington’S Disease Clinical Trial For Early-To Mid-Stage Patients, Considers Ways To Expand Research, Kenneth P. Serbin
Roche Ramps Up Huntington’S Disease Clinical Trial For Early-To Mid-Stage Patients, Considers Ways To Expand Research, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘We Can Now Fear Huntington’S Disease Less’: Reflections On The 14th Therapeutics Conference, Kenneth P. Serbin
‘We Can Now Fear Huntington’S Disease Less’: Reflections On The 14th Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Chdi’S Chief Scientist: ‘Not A Time For The Huntington's Community To Rest Its Laurels', Kenneth P. Serbin
Chdi’S Chief Scientist: ‘Not A Time For The Huntington's Community To Rest Its Laurels', Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Continued Progress, But Also Caution, In The Fight Against Huntington's Disease, Kenneth P. Serbin
Continued Progress, But Also Caution, In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Hacking Humans, Upgrading Homo Sapiens: The Role Of The Huntington's Disease Community And The Consequences For Life, Kenneth P. Serbin
Hacking Humans, Upgrading Homo Sapiens: The Role Of The Huntington's Disease Community And The Consequences For Life, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
A Friend Of The Huntington’S Community Receives Award For Hd Article In Influential Brazilian Magazine, Kenneth P. Serbin
A Friend Of The Huntington’S Community Receives Award For Hd Article In Influential Brazilian Magazine, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Announces U.S., Canada Sites For Phase 3 Clinical Trial Of Huntington's Disease Drug, Kenneth P. Serbin
Roche Announces U.S., Canada Sites For Phase 3 Clinical Trial Of Huntington's Disease Drug, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Building Solidarity In Disease Communities’ Quest For Better Care And Treatments: A Conversation With A Young Tennis Award-Winner, Kenneth P. Serbin
Building Solidarity In Disease Communities’ Quest For Better Care And Treatments: A Conversation With A Young Tennis Award-Winner, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
This Thanksgiving, Appreciating Stable Health And New Plans For Huntington's Disease Advocacy, Kenneth P. Serbin
This Thanksgiving, Appreciating Stable Health And New Plans For Huntington's Disease Advocacy, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Announces First Sites For Key Huntington’S Disease Observational Study, Kenneth P. Serbin
Roche Announces First Sites For Key Huntington’S Disease Observational Study, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Unpacking Generation Hd1, The Roche Phase 3 Huntington's Disease Clinical Trial, Kenneth P. Serbin
Unpacking Generation Hd1, The Roche Phase 3 Huntington's Disease Clinical Trial, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Phase 3 Clinical Trial For Huntington’S Disease Gene-Slicing Drug To Enroll Volunteers In Early 2019, Kenneth P. Serbin
Roche Phase 3 Clinical Trial For Huntington’S Disease Gene-Slicing Drug To Enroll Volunteers In Early 2019, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
In Harriet’S Tragic Death, The Vulnerability Caused By Huntington's Disease – But Also The Story Of A Beautiful Soul, Kenneth P. Serbin
In Harriet’S Tragic Death, The Vulnerability Caused By Huntington's Disease – But Also The Story Of A Beautiful Soul, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Free From The Threat Of Huntington’S Disease, Our 'Miracle Baby' Turns 18, Kenneth P. Serbin
Free From The Threat Of Huntington’S Disease, Our 'Miracle Baby' Turns 18, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin
New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin
Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin
Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin
In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin
The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.